Differential sensitivity of liposarcoma subtypes to chemotherapy

被引:277
作者
Jones, RL [1 ]
Fisher, C [1 ]
Al-Muderis, O [1 ]
Judson, IR [1 ]
机构
[1] Royal Marsden Hosp, Dept Med, Sarcoma Unit, London SW3 6JJ, England
关键词
liposarcoma; histological subtype; chemotherapy; response rate; differential sensitivity; myxoid liposarcoma;
D O I
10.1016/j.ejca.2005.07.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Liposarcoma is one of the most common soft tissue sarcomas and has a number of different subtypes: well-differentiated; dedifferentiated; myxoid/round cell; and pleomorphic. However, the response of these subgroups to chemotherapy is not well documented. In this study, we have conducted a retrospective analysis of a prospectively maintained database of soft tissue sarcoma patients treated at the Royal Marsden Hospital. Eighty-eight liposarcoma patients who received chemotherapy between August 1989 and June 2004 were identified. The response rates to chemotherapy of the different histological subtypes and overall and progression free survival were investigated. Survival according to histological grade was also assessed. A statistically significant higher response rate to first-line chemotherapy was observed in patients with myxoid liposarcoma compared to de- and well-differentiated tumours, 48% (95%CI; 28-69) and 11% (95%CI; 2-29), P = 0.005. Similarly, those with myxoid liposarcoma had a significantly higher response rate compared to all other liposarcoma patients, 48% (95%CI; 28-69) and 18% (95%CI; 8-31). Patients with lower grade tumours had better overall survival. This retrospective analysis suggests that myxoid liposarcoma is relatively chemosensitive in comparison to a combination of other liposarcomas, and in particular de- and well-differentiated tumours. Further confirmation of these results should be sought by similar analyses of other databases. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2853 / 2860
页数:8
相关论文
共 23 条
[1]  
COX DR, 1972, J R STAT SOC B, V34, P187
[2]   Pleomorphic liposarcoma: A clinicopathologic analysis of 19 cases [J].
Downes, KA ;
Goldblum, JR ;
Montgomery, EA ;
Fisher, C .
MODERN PATHOLOGY, 2001, 14 (03) :179-184
[3]   The impact of chemotherapy on the survival of patients with high-grade primary extremity liposarcoma [J].
Eilber, FC ;
Eilber, FR ;
Eckardt, J ;
Rosen, G ;
Riedel, E ;
Maki, RG ;
Brennan, MF ;
Singer, S .
ANNALS OF SURGERY, 2004, 240 (04) :686-695
[4]   Pleomorphic liposarcoma:: Clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases -: A study from the French Federation of Cancer Centers Sarcoma Group [J].
Gebhard, S ;
Coindre, JM ;
Michels, JJ ;
Terrier, P ;
Bertrand, G ;
Trassard, M ;
Taylor, S ;
Château, MC ;
Marquès, B ;
Picot, V ;
Guillou, L .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2002, 26 (05) :601-616
[5]   Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma [J].
Guillou, L ;
Coindre, JM ;
Bonichon, F ;
Bui, NB ;
Terrier, P ;
Collin, F ;
Vilain, MO ;
Mandard, AM ;
LeDoussal, V ;
Leroux, A ;
Jacquemier, J ;
Duplay, H ;
SastreGarau, X ;
Costa, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) :350-362
[6]   Dedifferentiated liposarcoma - A clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation [J].
Henricks, WH ;
Chu, YC ;
Goldblum, JR ;
Weiss, SW .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (03) :271-281
[7]   Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial [J].
Hensley, ML ;
Maki, R ;
Venkatraman, E ;
Geller, G ;
Lovegren, M ;
Aghajanian, C ;
Sabbatini, P ;
Tong, W ;
Barakat, R ;
Spriggs, DR .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (12) :2824-2831
[8]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[9]  
Kilpatrick SE, 1996, CANCER, V77, P1450, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1450::AID-CNCR5>3.0.CO
[10]  
2-G